Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

2 REIT stocks set to surge due to red hot data center demand: https://www.marketbeat.com/logos/articles/med_20240201055027_2-reit-stocks-set-to-surge-due-to-red-hot-data-cen.jpg
2 REIT stocks set to surge due to red hot data center demand

If there’s one industry that’s set to outgrow pretty much all others in the coming years, it’s data centers. At the start of last year, McKinsey said they were expecting demand to grow by at least

2 REIT stocks set to surge due to red hot data center demand: https://www.marketbeat.com/logos/articles/med_20240201055027_2-reit-stocks-set-to-surge-due-to-red-hot-data-cen.jpg
2 REIT stocks set to surge due to red hot data center demand

If there’s one industry that’s set to outgrow pretty much all others in the coming years, it’s data centers. At the start of last year, McKinsey said they were expecting demand to grow by at least

3 reasons airline stocks are a buy right now: https://www.marketbeat.com/logos/articles/med_20240131175542_3-reasons-airline-stocks-are-a-buy-right-now.jpg
3 reasons airline stocks are a buy right now

American Airlines Group Inc. (NASDAQ: AAL) is pulling back after its January 25 post-earnings gap higher. However, Wall Street sees reasons to buy not only American Airlines but other stocks in

Microsoft stock to $450? Here’s How: https://www.marketbeat.com/logos/articles/med_20240131081111_chart-msft-1312024-002ver001.png
Microsoft stock to $450? Here’s How

Microsoft’s (NASDAQ: MSFT) share price is driven by its growing position in the cloud. Late to the game, Microsoft has leaned hard into cloud and cloud services and AI, gaining share from Amazon

Microsoft stock to $450? Here’s How: https://www.marketbeat.com/logos/articles/med_20240131081111_chart-msft-1312024-002ver001.png
Microsoft stock to $450? Here’s How

Microsoft’s (NASDAQ: MSFT) share price is driven by its growing position in the cloud. Late to the game, Microsoft has leaned hard into cloud and cloud services and AI, gaining share from Amazon

Microsoft stock to $450? Here’s How: https://www.marketbeat.com/logos/articles/med_20240131081111_chart-msft-1312024-002ver001.png
Microsoft stock to $450? Here’s How

Microsoft’s (NASDAQ: MSFT) share price is driven by its growing position in the cloud. Late to the game, Microsoft has leaned hard into cloud and cloud services and AI, gaining share from Amazon

Microsoft stock to $450? Here’s How: https://www.marketbeat.com/logos/articles/med_20240131081111_chart-msft-1312024-002ver001.png
Microsoft stock to $450? Here’s How

Microsoft’s (NASDAQ: MSFT) share price is driven by its growing position in the cloud. Late to the game, Microsoft has leaned hard into cloud and cloud services and AI, gaining share from Amazon

3 big banking stocks that just got upgraded: https://www.marketbeat.com/logos/articles/med_20240131080410_3-big-banking-stocks-that-just-got-upgraded.jpg
3 big banking stocks that just got upgraded

With expectations rising for the Fed to cut rates sometime this year, banking stocks are very much back in focus. While it was looking like 2023 was going to go down as one of the poorer years in

Advanced Micro Devices is at a significant turning point: https://www.marketbeat.com/logos/articles/med_20240131071938_chart-amd-1312024ver001.png
Advanced Micro Devices is at a significant turning point

Advanced Micro Devices (NASDAQ: AMD) share price imploded following the Q4 release, but investors should not fear the move. The decline is a knee-jerk reaction to expected news, setting the market

Advanced Micro Devices is at a significant turning point: https://www.marketbeat.com/logos/articles/med_20240131071938_chart-amd-1312024ver001.png
Advanced Micro Devices is at a significant turning point

Advanced Micro Devices (NASDAQ: AMD) share price imploded following the Q4 release, but investors should not fear the move. The decline is a knee-jerk reaction to expected news, setting the market

Advanced Micro Devices is at a significant turning point: https://www.marketbeat.com/logos/articles/med_20240131071938_chart-amd-1312024ver001.png
Advanced Micro Devices is at a significant turning point

Advanced Micro Devices (NASDAQ: AMD) share price imploded following the Q4 release, but investors should not fear the move. The decline is a knee-jerk reaction to expected news, setting the market

2 upgraded food stocks with super-sized gain potential: https://www.marketbeat.com/logos/articles/med_20240130194102_2-upgraded-food-stocks-with-super-sized-gain-poten.jpg
2 upgraded food stocks with super-sized gain potential

If this week ends the way it started, the U.S. stock market will head into the weekend at fresh all-time highs.

Despite light news flow, the major indices posted heavy gains on Monday before

IBM, Verizon, Merck stocks lead Dow to new highs: https://www.marketbeat.com/logos/articles/med_20240130191144_ibm-verizon-merck-stocks-lead-dow-to-new-highs.jpg
IBM, Verizon, Merck stocks lead Dow to new highs

You don't hear as much about the Dow Jones Industrial Average as investors did a few decades ago, as the broad consensus has deemed the S&P 500 a better indicator of market conditions.

But the

IBM, Verizon, Merck stocks lead Dow to new highs: https://www.marketbeat.com/logos/articles/med_20240130191144_ibm-verizon-merck-stocks-lead-dow-to-new-highs.jpg
IBM, Verizon, Merck stocks lead Dow to new highs

You don't hear as much about the Dow Jones Industrial Average as investors did a few decades ago, as the broad consensus has deemed the S&P 500 a better indicator of market conditions.

But the

IBM stock jumps to 10-year high on accelerated AI growth: https://www.marketbeat.com/logos/articles/med_20240130184840_ibm-stock-jumps-to-10-year-high-on-accelerated-ai.jpg
IBM stock jumps to 10-year high on accelerated AI growth

International Business Machines (NYSE: IBM) stock is trading at its best levels in nearly 10 years. 

Take a look at the IBM chart: The stock is up 14.42% in the past month and up 32.47% in the

IBM stock jumps to 10-year high on accelerated AI growth: https://www.marketbeat.com/logos/articles/med_20240130184840_ibm-stock-jumps-to-10-year-high-on-accelerated-ai.jpg
IBM stock jumps to 10-year high on accelerated AI growth

International Business Machines (NYSE: IBM) stock is trading at its best levels in nearly 10 years. 

Take a look at the IBM chart: The stock is up 14.42% in the past month and up 32.47% in the

Med-tech stock Conmed dips ahead of big Q4 report...opportunity?: https://www.marketbeat.com/logos/articles/med_20240129182456_med-tech-stock-conmed-dips-ahead-of-big-q4-report.jpg
Med-tech stock Conmed dips ahead of big Q4 report...opportunity?

When Utica, NY-based medical technology company CONMED Corporation (NYSE:CNMD) reports fourth quarter financials after the close on Wednesday, it is expected to post some of its best growth in

4 med tech stocks with improving prognosis for 2024: https://www.marketbeat.com/logos/articles/med_20240130110415_chart-jnj-1302024ver001.png
4 med tech stocks with improving prognosis for 2024

Med tech stocks have been a mixed bag of results the last two years, with most moving within established trading ranges. The impact of COVID and its effect on procedure volumes were slow to

Starbucks perks up on margin strength: Are new highs in sight?: https://www.marketbeat.com/logos/articles/med_20240131120201_starbucks-perks-up-on-margin-strength-are-new-high.jpg
Starbucks perks up on margin strength: Are new highs in sight?

Starbucks Corporation (NASDAQ: SBUX) share prices perked up after the FQ1 release and guidance, but new highs are not in sight. The results were mixed, weak relative to the analysts' consensus

Starbucks perks up on margin strength: Are new highs in sight?: https://www.marketbeat.com/logos/articles/med_20240131120201_starbucks-perks-up-on-margin-strength-are-new-high.jpg
Starbucks perks up on margin strength: Are new highs in sight?

Starbucks Corporation (NASDAQ: SBUX) share prices perked up after the FQ1 release and guidance, but new highs are not in sight. The results were mixed, weak relative to the analysts' consensus

Starbucks perks up on margin strength: Are new highs in sight?: https://www.marketbeat.com/logos/articles/med_20240131120201_starbucks-perks-up-on-margin-strength-are-new-high.jpg
Starbucks perks up on margin strength: Are new highs in sight?

Starbucks Corporation (NASDAQ: SBUX) share prices perked up after the FQ1 release and guidance, but new highs are not in sight. The results were mixed, weak relative to the analysts' consensus

Crane can fly to new highs in 2024: https://www.marketbeat.com/logos/articles/med_20240130091347_crane-can-fly-to-new-highs-in-2024.jpg
Crane can fly to new highs in 2024

Crane (NYSE: CR) is a high-flying stock, having gained 58% since the IPO spin-off and keeping most of it. A recent downshift in analyst sentiment driven by valuation capped gains in January

Eilt: Durchbruch in der Krebsforschung - 22% der Patienten vollständig geheilt. Neuer 250% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73435/AC01-31-24-ax01.001.png
Eilt: Durchbruch in der Krebsforschung - 22% der Patienten vollständig geheilt. Neuer 250% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Eilt: Durchbruch in der Krebsforschung - 22% der Patienten vollständig geheilt. Neuer 250% Biotech Hot Stock nach 31205%

 

31.01.24 08:02

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

Eilt: Durchbruch in der Krebsforschung - 22% der Patienten vollständig geheilt. Neuer 250% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73435/AC01-31-24-ax01.001.png
Eilt: Durchbruch in der Krebsforschung - 22% der Patienten vollständig geheilt. Neuer 250% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Eilt: Durchbruch in der Krebsforschung - 22% der Patienten vollständig geheilt. Neuer 250% Biotech Hot Stock nach 31205%

 

31.01.24 08:02

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

Eilt: Durchbruch in der Krebsforschung - 22% der Patienten vollständig geheilt. Neuer 250% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73435/AC01-31-24-ax01.001.png
Eilt: Durchbruch in der Krebsforschung - 22% der Patienten vollständig geheilt. Neuer 250% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Eilt: Durchbruch in der Krebsforschung - 22% der Patienten vollständig geheilt. Neuer 250% Biotech Hot Stock nach 31205%

 

31.01.24 08:02

AC Research

 

London (www.aktiencheck.de, Anzeige)